(Q3)Jun 30, 2024 | (Q2)Mar 31, 2024 | (Q1)Dec 31, 2023 | (FY)Sep 30, 2023 | (Q4)Sep 30, 2023 | (Q3)Jun 30, 2023 | (Q2)Mar 31, 2023 | (Q1)Dec 31, 2022 | (FY)Sep 30, 2022 | (Q4)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 26.53%547.77K | -49.39%343.41K | -29.67%294.55K | 27.06%2.13M | 32.73%598.11K | 10.86%432.91K | 64.81%678.56K | -0.81%418.82K | -22.76%1.68M | -8.26%450.62K |
Operating revenue | 26.53%547.77K | -49.39%343.41K | -29.67%294.55K | 27.06%2.13M | 32.73%598.11K | 10.86%432.91K | 64.81%678.56K | -0.81%418.82K | -22.76%1.68M | -8.26%450.62K |
Cost of revenue | -51.65%236.63K | -59.80%224.48K | -60.12%232.89K | -23.38%1.97M | -52.23%339.25K | -36.27%489.44K | -12.90%558.4K | 28.77%583.98K | 21.36%2.57M | 48.05%710.15K |
Gross profit | 650.44%311.14K | -1.02%118.93K | 137.34%61.67K | 117.53%157.33K | 199.74%258.86K | 85.02%-56.53K | 152.39%120.16K | -428.77%-165.16K | -1,931.78%-897.54K | -2,349.35%-259.53K |
Operating expense | -36.26%290.5K | -61.75%289.03K | -54.77%293.04K | -20.05%2.45M | -31.42%587.64K | -48.70%455.76K | -1.50%755.64K | 18.16%647.93K | 44.45%3.06M | 49.82%856.82K |
Selling and administrative expenses | -20.88%211.41K | -60.34%230.01K | -48.72%195.83K | -19.62%1.88M | 9.72%654.83K | -55.30%267.18K | -14.97%579.91K | -18.24%381.89K | 29.46%2.34M | 14.93%596.81K |
-Selling and marketing expense | 25.21%23K | -85.15%7.96K | -83.74%8.8K | 13.75%140.08K | -54.66%13.97K | -66.22%18.37K | 108.38%53.59K | 342.11%54.16K | 48.21%123.15K | -6.37%30.8K |
-General and administrative expense | -24.28%188.41K | -57.81%222.06K | -42.93%187.03K | -21.47%1.74M | 13.22%640.87K | -54.21%248.82K | -19.80%526.32K | -27.95%327.74K | 28.56%2.22M | 16.37%566.01K |
Research and development costs | --0 | --0 | --0 | -115.36%-52.01K | -67.05%32.11K | -136.83%-47.1K | -240.34%-64.95K | -58.36%27.93K | 53.87%338.69K | 152.03%97.45K |
Depreciation amortization depletion | -95.07%7.54K | -95.06%7.57K | -82.92%26.71K | 62.57%615.16K | -6.06%152.7K | -6.02%152.96K | 294.02%153.12K | 1,000.05%156.37K | 328.17%378.39K | 1,062.89%162.56K |
-Depreciation and amortization | -95.07%7.54K | -95.06%7.57K | -82.92%26.71K | 62.57%615.16K | -6.06%152.7K | -6.02%152.96K | 294.02%153.12K | 1,000.05%156.37K | 328.17%378.39K | 1,062.89%162.56K |
Other operating expenses | -13.49%71.56K | -41.24%51.45K | -13.75%70.5K | ---- | ---- | --82.72K | --87.56K | --81.74K | ---- | ---- |
Operating profit | 104.03%20.64K | 73.23%-170.1K | 71.54%-231.37K | 42.16%-2.29M | 70.55%-328.78K | 59.53%-512.28K | 36.23%-635.48K | -40.28%-813.09K | -91.24%-3.96M | -99.21%-1.12M |
Net non-operating interest income (expenses) | -8.58%-31.11K | -25.24%-31.02K | 24.10%-29.64K | 4.76%-121.07K | 17.96%-28.6K | 11.75%-28.65K | 19.56%-24.77K | -34.61%-39.05K | -1.08%-127.12K | -29.51%-34.85K |
Non-operating interest income | 28.45%781 | -62.94%272 | 28.71%529 | 33.51%1.99K | -34.34%239 | 428.70%608 | --734 | -59.43%411 | -80.79%1.49K | -84.72%364 |
Non-operating interest expense | 9.00%31.89K | 22.70%31.29K | -23.55%30.17K | -4.32%123.06K | -18.13%28.83K | -10.20%29.26K | -17.18%25.5K | 31.44%39.47K | -3.68%128.62K | 20.22%35.22K |
Other net income (expenses) | 109.54%697 | 103.36%136 | -99.97%63 | -3,732.45%-663.1K | -4,719.70%-851.13K | -157.93%-7.31K | 67.03%-4.05K | 39,349.21%199.39K | 141.73%18.26K | -48.46%18.42K |
Gain on sale of security | 109.54%697 | 103.36%136 | 101.23%63 | -196.09%-17.66K | -106.32%-1.17K | -157.93%-7.31K | 67.03%-4.05K | -910.43%-5.13K | 145.74%18.38K | 87.68%18.55K |
Special income (charges) | --0 | --0 | --0 | -520,418.55%-645.44K | -685,353.23%-849.96K | --0 | --0 | --204.52K | 96.52%-124 | -100.48%-124 |
-Less:Impairment of capital assets | ---- | ---- | ---- | --870.41K | ---- | ---- | ---- | ---- | --0 | ---- |
-Less:Other special charges | ---- | ---- | ---- | ---204.52K | ---1 | ---- | ---- | ---204.52K | ---- | ---- |
-Less:Write off | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -96.52%124 | ---- |
-Gain on sale of property,plant,equipment | ---- | ---- | ---- | --20.44K | ---- | ---- | ---- | ---- | --0 | ---- |
Income before tax | 98.22%-9.77K | 69.75%-200.98K | 60.02%-260.95K | 24.42%-3.07M | -6.68%-1.21M | 57.36%-548.24K | 36.10%-664.3K | -7.16%-652.76K | -81.62%-4.07M | -105.38%-1.13M |
Income tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Earnings from equity interest net of tax | ||||||||||
Net income | 98.22%-9.77K | 69.75%-200.98K | 60.02%-260.95K | 24.42%-3.07M | -6.68%-1.21M | 57.36%-548.24K | 36.10%-664.3K | -7.16%-652.76K | -81.62%-4.07M | -105.38%-1.13M |
Net income continuous operations | 98.22%-9.77K | 69.75%-200.98K | 60.02%-260.95K | 24.42%-3.07M | -6.68%-1.21M | 57.36%-548.24K | 36.10%-664.3K | -7.16%-652.76K | -81.62%-4.07M | -105.38%-1.13M |
Noncontrolling interests | ||||||||||
Net income attributable to the company | 98.22%-9.77K | 69.75%-200.98K | 60.02%-260.95K | 24.42%-3.07M | -6.68%-1.21M | 57.36%-548.24K | 36.10%-664.3K | -7.16%-652.76K | -81.62%-4.07M | -105.38%-1.13M |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | ||||||||||
Net income attributable to common stockholders | 98.22%-9.77K | 69.75%-200.98K | 60.02%-260.95K | 24.42%-3.07M | -6.68%-1.21M | 57.36%-548.24K | 36.10%-664.3K | -7.16%-652.76K | -81.62%-4.07M | -105.38%-1.13M |
Diluted earnings per share | 99.18%-0.0001 | 82.76%-0.0017 | 74.48%-0.0026 | 50.00%-0.04 | 66.67%-0.01 | 50.00%-0.01 | 50.00%-0.01 | 50.00%-0.01 | -33.33%-0.08 | -200.00%-0.03 |
Basic earnings per share | 99.18%-0.0001 | 82.76%-0.0017 | 74.48%-0.0026 | 50.00%-0.04 | 66.67%-0.01 | 50.00%-0.01 | 50.00%-0.01 | 50.00%-0.01 | -33.33%-0.08 | -200.00%-0.03 |
Dividend per share | ||||||||||
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data